What is the history of Breast Cancer?

Breast cancer has been documented since antiquity, with the earliest known account appearing in an Egyptian papyrus around 1600 BCE. While early medical traditions viewed breast cancer as an incurable systemic imbalance, modern medicine has transformed our understanding of the disease into a complex, heterogeneous condition driven by genetic, hormonal, and environmental factors.

When was breast cancer first described in medical literature?

The history of breast cancer is one of the oldest recorded medical narratives. The Edwin Smith Papyrus, dating back to ancient Egypt, describes eight cases of tumors or ulcers of the breast that were treated by cauterization with a tool called the "fire drill." At the time, the text noted that there was "no treatment." The ancient Greek physician Hippocrates later termed the disease "karkinos" (crab) because the swollen veins surrounding a tumor resembled the legs of a crab, a descriptive term that remains the root of the word "carcinoma" today.

How have our misconceptions about breast cancer evolved?

For centuries, the medical community operated under the "humoral theory," which posited that breast cancer was caused by an excess of "black bile" in the body. Physicians believed that surgery was often futile because they misunderstood the disease as a systemic condition rather than a localized one that could metastasize. It was not until the 19th and early 20th centuries, led by surgeons like William Halsted, that breast cancer was understood to spread through the lymphatic system, leading to the development of the radical mastectomy. While aggressive, this era marked the first time surgery was approached with a systematic, anatomical understanding of the disease's progression.

What are the major milestones in the treatment of breast cancer?

The treatment landscape for breast cancer has shifted from radical, disfiguring surgeries to highly personalized, targeted therapies. Key milestones include:

• 1882: William Halsted introduces the radical mastectomy, which remained the standard of care for nearly a century.


• 1970s: The transition to breast-conserving surgery (lumpectomy) combined with radiation therapy, proving that less invasive surgery could be as effective as radical procedures.


• 1977: The FDA approval of Tamoxifen, the first targeted hormonal therapy, revolutionized the management of hormone receptor-positive breast cancer.


• 1998: Approval of Trastuzumab (Herceptin), a breakthrough monoclonal antibody targeting the HER2 protein, significantly improving outcomes for patients with HER2-positive disease.

How has modern genetics changed our perspective?

The discovery of the BRCA1 and BRCA2 gene mutations in the 1990s fundamentally altered the paradigm of breast cancer care. We now recognize that approximately 5% to 10% of all breast cancer cases are hereditary. This genetic revolution has enabled "precision oncology," where treatment plans are tailored to the specific molecular profile of a tumor rather than just its location or size. Today, 110 members of the DiseaseMaps.org community are actively sharing their lived experiences, reflecting how patient advocacy has moved from the shadows to the forefront of research, driving funding and awareness for early detection and survivorship.

Next steps

• Consult with an oncologist or a genetic counselor if you have a strong family history of breast or ovarian cancer.


• Schedule regular screenings as recommended by your physician based on your personal risk profile.


• Join the community at DiseaseMaps.org to connect with others who have navigated the path of breast cancer diagnosis and treatment.


• Stay informed about clinical trials through official portals like ClinicalTrials.gov to see if you are eligible for emerging, cutting-edge therapies.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Cancer Institute (NCI) - Breast Cancer (PDQ®) Treatment Overview


• NIH Genetic and Rare Diseases Information Center (GARD)


• American Cancer Society (ACS) - History of Breast Cancer Treatment


• Orphanet: Portal for rare diseases and orphan drugs